{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:51:50Z","timestamp":1791906710930,"version":"4.3.4"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100009848","name":"Tower Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009848","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Landon Foundation-American Association for Cancer Research Innovator Award For Cancer Prevention Research"},{"name":"NIH National Institution of Diabetes, Digestive and Kidney Disease"},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytother. Res."],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1002\/ptr.5518","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T09:17:41Z","timestamp":1448961461000},"page":"160-168","source":"Crossref","is-referenced-by-count":99,"title":["A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C"],"prefix":"10.1002","volume":"30","author":[{"given":"Nu T.","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine; University of California Los Angeles; Los Angeles USA"},{"name":"Department of Hematology and Oncology; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Crespi","sequence":"additional","affiliation":[{"name":"Fielding School of Public Health, Department of Biostatistics; University of California Los Angeles; Los Angeles USA"},{"name":"Jonsson Comprehensive Cancer Center, Center for Cancer Prevention and Control; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie M.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Q.","family":"Vu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Ahmadieh","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine; Touro University; Vallejo USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Fielding School of Public Health, Department of Biostatistics; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Lin","sequence":"additional","affiliation":[{"name":"Neuromodulation Division; Boston Scientific Inc.; Valencia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McClune","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery; Kaiser Permanente Sunset; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Durazo","sequence":"additional","affiliation":[{"name":"Pfleger Liver Institute; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[{"name":"Pfleger Liver Institute; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Han","sequence":"additional","affiliation":[{"name":"Pfleger Liver Institute; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Neiman","sequence":"additional","affiliation":[{"name":"Human Performance Laboratory; Appalachian State University- North Carolina Research Campus; Kannapolis USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Beaven","sequence":"additional","affiliation":[{"name":"Pfleger Liver Institute; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.","family":"French","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine; University of California Los Angeles; Los Angeles USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"issue":"2","key":"10.1002\/ptr.5518-BIB0001|ptr5518-cit-0001","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(00)00645-5","article-title":"Interaction of quercetin glucosides with the intestinal sodium\/glucose co-transporter (SGLT-1)","volume":"162","author":"Ader","year":"2001","journal-title":"Cancer Lett"},{"issue":"16","key":"10.1002\/ptr.5518-BIB0002|ptr5518-cit-0002","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014a","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1002\/ptr.5518-BIB0003|ptr5518-cit-0003","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014b","journal-title":"N Engl J Med"},{"issue":"3 Suppl 1","key":"10.1002\/ptr.5518-BIB0004|ptr5518-cit-0004","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1002\/hep.510260711","article-title":"Epidemiology of hepatitis C","volume":"26","author":"Alter","year":"1997","journal-title":"Hepatology"},{"issue":"10","key":"10.1002\/ptr.5518-BIB0005|ptr5518-cit-0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1002\/ptr.5518-BIB0006|ptr5518-cit-0006","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","article-title":"Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity","volume":"19","author":"Bachmetov","year":"2012","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1002\/ptr.5518-BIB0007|ptr5518-cit-0007","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"issue":"15","key":"10.1002\/ptr.5518-BIB0008|ptr5518-cit-0008","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1128\/JVI.00645-12","article-title":"Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A","volume":"86","author":"Bhattacharya","year":"2012","journal-title":"J Virol"},{"issue":"8","key":"10.1002\/ptr.5518-BIB0009|ptr5518-cit-0009","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jn\/138.8.1417","article-title":"Tissue distribution of quercetin in pigs after long-term dietary supplementation","volume":"138","author":"Bieger","year":"2008","journal-title":"J Nutr"},{"issue":"3","key":"10.1002\/ptr.5518-BIB0010|ptr5518-cit-0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1055-9965.EPI-07-2523","article-title":"Flavonoid intake and risk of pancreatic cancer in male smokers (Finland)","volume":"17","author":"Bobe","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1002\/ptr.5518-BIB0011|ptr5518-cit-0011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1211\/0022357991772367","article-title":"Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism","volume":"51","author":"Boulton","year":"1999","journal-title":"J Pharm Pharmacol"},{"issue":"368","key":"10.1002\/ptr.5518-BIB0012|ptr5518-cit-0012","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots","volume":"74","author":"Cleveland","year":"1979","journal-title":"J Am Stat Assoc"},{"issue":"12","key":"10.1002\/ptr.5518-BIB0013|ptr5518-cit-0013","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0891-5849(00)00416-0","article-title":"Conjugation position of quercetin glucuronides and effect on biological activity","volume":"29","author":"Day","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1002\/ptr.5518-BIB0014|ptr5518-cit-0014","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-136-4-200202190-00008","article-title":"Surprisingly small effect of antiviral treatment in patients with hepatitis C","volume":"136","author":"Falck-Ytter","year":"2002","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1002\/ptr.5518-BIB0015|ptr5518-cit-0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000233423","article-title":"Quercetin inhibits anaphylactic contraction of guinea pig ileum smooth muscle","volume":"71","author":"Fanning","year":"1983","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0016|ptr5518-cit-0016","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/hep.26641","article-title":"Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naive genotype 1 hepatitis C: the randomized PILLAR study","volume":"58","author":"Fried","year":"2013","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/ptr.5518-BIB0017|ptr5518-cit-0017","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/jn\/130.11.2765","article-title":"Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway","volume":"130","author":"Gee","year":"2000","journal-title":"J Nutr"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0018|ptr5518-cit-0018","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/hep.23232","article-title":"The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production","volume":"50","author":"Gonzalez","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/ptr.5518-BIB0019|ptr5518-cit-0019","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.fct.2007.05.015","article-title":"A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic\/carcinogenic properties","volume":"45","author":"Harwood","year":"2007","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1002\/ptr.5518-BIB0020|ptr5518-cit-0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2010.05.001","article-title":"Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial","volume":"62","author":"Heinz","year":"2010a","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0021|ptr5518-cit-0021","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/S000711451000156X","article-title":"A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects","volume":"104","author":"Heinz","year":"2010b","journal-title":"Br J Nutr"},{"issue":"5 Suppl 1","key":"10.1002\/ptr.5518-BIB0023|ptr5518-cit-0023","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/ptr.5518-BIB0024|ptr5518-cit-0024","doi-asserted-by":"crossref","first-page":"e80843","DOI":"10.1371\/journal.pone.0080843","article-title":"Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages","volume":"8","author":"Ishisaka","year":"2013","journal-title":"PLoS One"},{"issue":"9883","key":"10.1002\/ptr.5518-BIB0025|ptr5518-cit-0025","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(13)60247-0","article-title":"Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial","volume":"381","author":"Kowdley","year":"2013","journal-title":"Lancet"},{"issue":"20","key":"10.1002\/ptr.5518-BIB0026|ptr5518-cit-0026","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12\u2009weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/ptr.5518-BIB0027|ptr5518-cit-0027","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1139\/H07-177","article-title":"Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation","volume":"33","author":"McAnulty","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0028|ptr5518-cit-0028","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1002\/ptr.5518-BIB0029|ptr5518-cit-0029","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1152\/japplphysiol.00707.2007","article-title":"Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA","volume":"103","author":"Nieman","year":"2007a","journal-title":"J Appl Physiol"},{"issue":"9","key":"10.1002\/ptr.5518-BIB0030|ptr5518-cit-0030","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1249\/mss.0b013e318076b566","article-title":"Quercetin reduces illness but not immune perturbations after intensive exercise","volume":"39","author":"Nieman","year":"2007b","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0031|ptr5518-cit-0031","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.3390\/ijms12064027","article-title":"Systematic approaches towards the development of host-directed antiviral therapeutics","volume":"12","author":"Prussia","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1002\/ptr.5518-BIB0032|ptr5518-cit-0032","unstructured":"Rogatko A Xu TM 2005 EWOC User's Guide Version 2.0 http:\/\/www.sph.emory.edu\/BRI-WCI\/ewoc.html"},{"issue":"11","key":"10.1002\/ptr.5518-BIB0033|ptr5518-cit-0033","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/ptr.5023","article-title":"Novel insights into the pharmacology of flavonoids","volume":"27","author":"Romano","year":"2013","journal-title":"Phytother Res"},{"issue":"3","key":"10.1002\/ptr.5518-BIB0034|ptr5518-cit-0034","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jn\/133.3.773","article-title":"Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase","volume":"133","author":"Sesink","year":"2003","journal-title":"J Nutr"},{"issue":"2","key":"10.1002\/ptr.5518-BIB0035|ptr5518-cit-0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/10715760903407293","article-title":"Quercetin supplementation does not alter antioxidant status in humans","volume":"44","author":"Shanely","year":"2010","journal-title":"Free Radic Res"},{"issue":"11","key":"10.1002\/ptr.5518-BIB0036|ptr5518-cit-0036","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1097\/01.tp.0000183290.64309.21","article-title":"Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial","volume":"80","author":"Shoskes","year":"2005","journal-title":"Transplantation"},{"issue":"11","key":"10.1002\/ptr.5518-BIB0037|ptr5518-cit-0037","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ptr.5447","article-title":"Recent trends in preclinical drug-drug interaction studies of flavonoids - review of case studies, issues and perspectives","volume":"29","author":"Srinivas","year":"2015","journal-title":"Phytother Res"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0038|ptr5518-cit-0038","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/ptr.5518-BIB0039|ptr5518-cit-0039","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2893.2005.00615.x","article-title":"Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy","volume":"12","author":"Terrault","year":"2005","journal-title":"J Viral Hepat"},{"issue":"14","key":"10.1002\/ptr.5518-BIB0040|ptr5518-cit-0040","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/sim.2106","article-title":"Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control","volume":"24","author":"Tighiouart","year":"2005","journal-title":"Stat Med"},{"issue":"8","key":"10.1002\/ptr.5518-BIB0041|ptr5518-cit-0041","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1021\/jf0636014","article-title":"Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial","volume":"55","author":"Valentova","year":"2007","journal-title":"J Agric Food Chem"},{"issue":"10","key":"10.1002\/ptr.5518-BIB0042|ptr5518-cit-0042","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jn\/131.10.2648","article-title":"Carbon dioxide is the major metabolite of quercetin in humans","volume":"131","author":"Walle","year":"2001","journal-title":"J Nutr"},{"issue":"2","key":"10.1002\/ptr.5518-BIB0043|ptr5518-cit-0043","first-page":"1","article-title":"Surveillance for acute viral hepatitis-United States, 2006","volume":"57","author":"Wasley","year":"2008","journal-title":"MMWR Surveill Summ"},{"issue":"6","key":"10.1002\/ptr.5518-BIB0044|ptr5518-cit-0044","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/apt.13081","article-title":"Cost-effectiveness of all-oral ledipasvir\/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection","volume":"41","author":"Younossi","year":"2015","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Phytotherapy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fptr.5518","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fptr.5518","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ptr.5518\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T16:33:43Z","timestamp":1748709223000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ptr.5518"}},"subtitle":["QUERCETIN AND HEPATITIS C"],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ptr.5518","archive":["Portico"],"relation":{},"ISSN":["0951-418X"],"issn-type":[{"value":"0951-418X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,1]]}}}